» Articles » PMID: 21734404

Genome-wide Linkage Analysis to Identify Genetic Modifiers of ALK Mutation Penetrance in Familial Neuroblastoma

Overview
Journal Hum Hered
Specialty Genetics
Date 2011 Jul 8
PMID 21734404
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Neuroblastoma (NB) is an important childhood cancer with a strong genetic component related to disease susceptibility. Approximately 1% of NB cases have a positive family history. Following a genome-wide linkage analysis and sequencing of candidate genes in the critical region, we identified ALK as the major familial NB gene. Dominant mutations in ALK are found in more than 50% of familial NB cases. However, in the families used for the linkage study, only about 50% of carriers of ALK mutations are affected by NB.

Methods: To test whether genetic variation may explain the reduced penetrance of the disease phenotype, we analyzed genome-wide genotype data in ALK mutation-positive families using a model-based linkage approach with different liability classes for carriers and non-carriers of ALK mutations.

Results: The region with the highest LOD score was located at chromosome 2p23-p24 and included the ALK locus under models of dominant and recessive inheritance.

Conclusions: This finding suggests that variants in the non-mutated ALK gene or another gene linked to it may affect penetrance of the ALK mutations and risk of developing NB in familial cases.

Citing Articles

Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants.

Przybyla W, Gjersvoll Paulsen K, Mishra C, Nygard S, Engebretsen S, Ruud E PLoS One. 2022; 17(8):e0273280.

PMID: 36037157 PMC: 9423626. DOI: 10.1371/journal.pone.0273280.


ALK expression, prognostic significance, and its association with MYCN expression in MYCN non-amplified neuroblastoma.

Somasundaram D, Aravindan S, Gupta N, Yu Z, Baker A, Aravindan N World J Pediatr. 2022; 18(4):285-293.

PMID: 35132576 DOI: 10.1007/s12519-022-00517-5.


A review of the biological and clinical implications of RAS-MAPK pathway alterations in neuroblastoma.

Mlakar V, Morel E, Jurkovic Mlakar S, Ansari M, Gumy-Pause F J Exp Clin Cancer Res. 2021; 40(1):189.

PMID: 34103089 PMC: 8188681. DOI: 10.1186/s13046-021-01967-x.


Anaplastic Lymphoma Kinase (ALK) Receptor Tyrosine Kinase: A Catalytic Receptor with Many Faces.

Huang H Int J Mol Sci. 2018; 19(11).

PMID: 30400214 PMC: 6274813. DOI: 10.3390/ijms19113448.


Relevance of polymorphisms to neuroblastoma risk in Chinese children: a four-center case-control study.

Cheng J, Zhuo Z, Xin Y, Zhao P, Yang W, Zhou H Aging (Albany NY). 2018; 10(8):1989-2000.

PMID: 30089098 PMC: 6128416. DOI: 10.18632/aging.101522.


References
1.
Mosse Y, Laudenslager M, Longo L, Cole K, Wood A, Attiyeh E . Identification of ALK as a major familial neuroblastoma predisposition gene. Nature. 2008; 455(7215):930-5. PMC: 2672043. DOI: 10.1038/nature07261. View

2.
McGee T, Devoto M, Ott J, Berson E, Dryja T . Evidence that the penetrance of mutations at the RP11 locus causing dominant retinitis pigmentosa is influenced by a gene linked to the homologous RP11 allele. Am J Hum Genet. 1997; 61(5):1059-66. PMC: 1716046. DOI: 10.1086/301614. View

3.
Randon J, Boulanger L, MARECHAL J, Garbarz M, Vallier A, Ribeiro L . A variant of spectrin low-expression allele alpha LELY carrying a hereditary elliptocytosis mutation in codon 28. Br J Haematol. 1994; 88(3):534-40. DOI: 10.1111/j.1365-2141.1994.tb05070.x. View

4.
Longo L, Panza E, Schena F, Seri M, Devoto M, Romeo G . Genetic predisposition to familial neuroblastoma: identification of two novel genomic regions at 2p and 12p. Hum Hered. 2007; 63(3-4):205-11. DOI: 10.1159/000099997. View

5.
Abecasis G, Cherny S, Cookson W, Cardon L . Merlin--rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet. 2001; 30(1):97-101. DOI: 10.1038/ng786. View